2021 Legislative Session: Week 12
Legislative Days 39- 40 – Sine Die!
GPhA Priority legislation makes its way to the Governor’s desk.
SB46
The final two legislative days were a whirlwind for GPhA with two big bills still in play. As SB 46 (pharmacist vaccine expansion) was set for a floor vote, misinformation and misunderstanding about the bill made its way across the internet like wildfire. Thankfully, Georgia’s pharmacists answered the call and reached out to legislators to set the record straight about what this bill does and why this bill is critical for Georgians. Ultimately, the legislation passed the House via substitute on day 40, Sine Die, by a vote of 109 to 56. It then made is way to the Senate where it was agreed to at 11:55 p.m. It now goes to the Governor’s desk for his consideration.
A huge thank you to Georgia’s pharmacists who stepped up like never before to fight for this bill, GPhA’s Board of Directors, GPhA CEO Bob Coleman who never wavered and rallied the troops, the GPhA communications team of Michelle Turkington and Andrew Kantor, and GPhA’s lobbyist, Cindy Shepherd. Also, a big thank you to Dorothy-Leonne Glasser with the Rx in Reach Coalition.
There are too many legislators to thank who helped get this bill across the finish line but set forth below are a few legislators and leaders who deserve a special thank you.
- Senators Dean Burke, Bo Hatchett, Kay Kirkpatrick, Jeff Mullis, Ben Watson
- House Speaker David Ralston and representatives Sharon Cooper, Matt Hatchett, Rick Jasperse, Trey Kelley, David Knight, Mark Newton, Bert Reeves, Ron Stephens, and Richard Smith.
- And a special thank-you to Governor Kemp and his healthcare team, the Department of Public Health and their government affairs team, and Lieutenant Governor Duncan and his team.
HB653
More good news, HB 653 (Pharmacists conducting COVID testing for 12 months after the end of the federal emergency) also passed the Senate on day forty. This one was a bit less controversial receiving a vote of 48-0. A huge thank you to Representative Rick Jasperse and Senators Ben Watson and Chuck Hofstetler for bringing this bill to the finish line. It now goes to Governor Kemp for his consideration.
Set forth below are other bills GPhA monitored and where they ended up. Finally, it was worth mentioning that several other significant bills ended up failing to pass this year including HB 369 (expand PA & NP prescribing authority) and HB 290 (allowing hospital and nursing home visitation by patient designated family member or friend during public health emergency).
Passed and Await Governor Kemp’s Consideration
- HB 93 (Eliminating duplicative state licensure and regulation of clinical laboratories)
- HB 112 (Extending COVID-19 immunity protections for businesses and healthcare providers to July 2022)
- HB 234 (Option for self-funded healthcare plans to opt into Georgia’s Surprise Billing Consumer Protection Act)
- HB 316 (expanding pharmacist to technician ratio to 4-1 provided that 2 of the 4 technicians are certified)
- HB 367 (Drug update)
- HB 454 (Providing for certain coverage requirements concerning providers that become out-of-network during a plan year)
- SB 195 (Medical cannabis and epidiolex) (previously HB 645 & HB 601 respectively)
- SB 80 (Prior authorization)
- SB 215 (Authorizing certified medication aides to administer certain medications to patients in nursing homes and requiring nursing homes that use certified medication aides to secure the services of a licensed pharmacist as part of a nursing homes quality assurance functions)
Did Not Pass
- HB 49 (Mental Health Parity Act requiring drug plans to include coverage for mental health conditions)
- HB 73 (Insulin copay cap at $50)
- HB 164 (Requiring insurers pass back 80% of rebates to patients at prescription drug counter)
- HB 413 (Prohibiting state or local governments from requiring individuals to submit to vaccinations as a condition to certain actions if the vaccine does not meet certain conditions)
- HB 447 (SHBP transparency)
- HB 448 (Medicaid managed care transparency)
- HB 474 (Requiring concurrent prescribing of n opioid antagonist with opioids under certain circumstances)
- HB 592 (Clarifying gross negligence standard in actions involving COVID-19 liability claims against healthcare providers)
- HB 601 (Removing Epidiolex as a Schedule V controlled substance – passed as SB 195)
- HB 645 (Making changes to Georgia’s existing medical cannabis law – passed as SB 195)
- SB 1 (Providing that entities that receive certain tax credits and that provide self-funded, employer sponsored insurance plans are submitting entities)
- SB 92 (Prohibiting the sale to and by minors of OTC drug products containing dextromethorphan)
- SB 181 (Reducing out-of-pocket cost of consumers requiring insulin)